Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). - Wikidata - awgldk - TriplyDB

Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96).

Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96).

http://www.wikidata.org/entity/Q31002124

about

Chemotherapy versus surgery with or without adjuvant chemotherapy and radiotherapy for localised primary gastric diffuse large B-cell lymphoma Chemotherapy versus surgery with or without adjuvant chemotherapy and radiotherapy for localised primary gastric diffuse large B-cell lymphoma Rare gastrointestinal lymphomas: The endoscopic investigation Diffuse large B cell gastric lymphoma a rare disease: the effort to obtain scientific data in a multicenter, multinational retrospective trial Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma: dosimetric comparison and risk assessment of solid secondary cancer.Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors.Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL).Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology.Radiotherapy for gastric lymphoma: a planning study of 3D conformal radiotherapy, the half-beam method, and intensity-modulated radiotherapy.Refractory peptic ulceration following radiation therapy in primary gastric lymphoma: A report of two cases Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.Primary non-hodgkin lymphoma of the stomach: clinicopathological characteristics and prognostic factors in Iranian patients HCC and angiogenesis: possible targets and future directions Primary gastric lymphoma: conservative treatment modality is not inferior to surgery for early-stage disease.Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP.Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.Hepatic dysfunction after radiotherapy for primary gastric lymphoma.Primary gastrointestinal tract lymphoma: diagnosis and management of common neoplasms.Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?Radiotherapy for low-grade gastric marginal zone lymphoma: a retrospective study.Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.Therapy of gastric mucosa-associated lymphoid tissue lymphoma.Therapy of gastric mucosa associated lymphoid tissue lymphoma.Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study.Therapeutic comparison of chemotherapy and surgery for early stage diffuse large B-cell gastric lymphoma.Clinical Significance of "Double-hit" and "Double-protein" expression in Primary Gastric B-cell Lymphomas.Risk factors and patterns of lymph node involvement in primary gastric large B-cell lymphoma: implications for target definition Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management.A case of Helicobactor pylori negative low-grade gastric MALT lymphoma in an elderly female, successfully treated with rituximab.Gastric infiltration of diffuse large B-cell lymphoma: endoscopic diagnosis and improvement of lesions after chemotherapy.Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era.Molecular therapy for the treatment of hepatocellular carcinoma.Composite lymphoma with relapse of enteropathy-type T-cell lymphoma.Targeted therapy for hepatocellular carcinoma.Analysis of clinical characteristics, diagnosis, treatment and prognosis of 46 patients with primary gastrointestinal non-Hodgkin lymphoma.Novel inhibitors in development for hepatocellular carcinoma.Latest developments in targeted therapy for hepatocellular carcinoma.

P2860

Q24186267-D6886BBF-217B-45A2-B189-23CDFE9E87D1 Q24197592-5F8FCBD6-ECE2-41AD-8636-781D5B3A4665 Q26799041-0EDA17E5-781A-4654-9C7B-9A32E599C697 Q31121542-9B29DCF9-8232-4311-9375-E35CD1212245 Q33242286-63DB215A-E71C-4575-9154-C65F1EB76C53 Q33583912-056FF8A5-B6B1-4623-8058-0F8D1E39D109 Q33626074-1F9FB63E-1FF0-4D4A-95CA-D7E12CDFF718 Q33974375-0D39B3CB-506B-458B-821A-7DD3781D733F Q34226740-98BBC227-5A1F-4AC4-9B14-A1F14729550E Q34500937-1F457A56-5882-4508-8CE8-B7DC6656DD7C Q34583827-A50AFCA7-75DE-418A-B6DC-2D53F2B569ED Q34600972-BC9F686A-010B-4443-9600-9C8382E9C2B7 Q34653557-D60A6C18-0F3D-475F-98AF-9CC79E00C7FD Q35015908-ED3D7FE5-3DF9-4214-8747-3120752C6556 Q35698574-55D77EC1-407D-4960-AEF7-D623BF3CB85A Q36220969-A643CFB8-C43C-4F87-B9ED-E46E68BCC00B Q36224763-30971EE5-A319-414F-83A2-B48F5C33E92D Q36407449-3532AD78-BBD6-407A-93C8-F18EC67CDA8E Q36499990-BF36DAD4-0D1D-4294-94C0-A4A54107CED5 Q36668251-BE335F83-CE7C-4DA2-861B-0C9922A99C62 Q36677699-D99A15BC-EC24-47AC-9AAA-DFF3E02404EC Q36742694-A6B43C43-B58A-4565-8B2C-8397807426A9 Q36768594-BA18601C-EB53-4890-B39E-C9079C5A3097 Q36847291-8CC28450-A94A-4A0E-B773-5E0C4862E348 Q36894785-3F83B5A3-D009-4845-990C-10B85CDBDEA5 Q36936952-E3446D32-94B0-4654-B0E1-4CAD192188A4 Q37065745-8E6FD748-3BF0-43A1-B399-BC9EAAF609FA Q37067986-BA7DF53D-14A1-4DF1-863C-8757F20923A2 Q37152531-BEF66F2E-B815-411A-A0B9-74D819B98A46 Q37164940-5C6C211E-12A7-45ED-8A05-B5E513C5A0F1 Q37224102-CDD37837-9BBE-44F2-9644-EBB164D4A4A1 Q37313226-37E99003-AD4B-4C7D-9663-9419E2008FC1 Q37316699-F0065D4F-EFC8-4CAD-9007-F255E8FEB4E1 Q37325037-C02C5173-2EE5-41F9-B15C-B8D8350D176D Q37329048-0602DEB9-7A4F-4E91-8EDF-AE321AFA4A85 Q37426446-30F1710E-2F17-442B-B3BA-994854770447 Q37504684-1880A526-3333-4ED6-8453-87A1BEA19C42 Q37567822-A2E20BFC-2F76-4792-9E72-7734A2A79F18 Q37725994-678BA2D0-E973-455D-85F1-A91E2BCF8889 Q37799829-DFD4F707-DE9F-42BE-A8A7-501769A4C493

P2860

Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96).

http://www.wikidata.org/entity/Q31002124

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Treatment results in localized ...... icenter study (GIT NHL 02/96).

@ast

Treatment results in localized ...... icenter study (GIT NHL 02/96).

@en

type

label

Treatment results in localized ...... icenter study (GIT NHL 02/96).

@ast

Treatment results in localized ...... icenter study (GIT NHL 02/96).

@en

prefLabel

Treatment results in localized ...... icenter study (GIT NHL 02/96).

@ast

Treatment results in localized ...... icenter study (GIT NHL 02/96).

@en

P1433

Q31002124-7F43D596-5A96-4EB5-B252-5AD241861E02

P1476

Q31002124-2572A406-063A-4C97-BD01-2A2790E6049D

P2093

Q31002124-045DD363-AB6A-42C9-B817-9B31B48A7681

Q31002124-052367C6-25E5-49BD-AB10-C65120455252

Q31002124-17535A00-BA5B-45C7-B1AF-29FCEFF008AC

Q31002124-42199395-B7A2-4E4D-B499-1A50532C4175

Q31002124-442D8EEA-DD93-4ED2-BEF7-AB4595A8A94B

Q31002124-57BB6380-B957-4873-877E-CFA3FC979B3E

Q31002124-5940C6C1-28FC-4927-B7C8-3142AAE31DB1

Q31002124-5E7E58B4-C937-4EF8-9F47-1C8E5605EDF7

Q31002124-7CDA0472-BE0C-4511-B33B-BFCEF3FB475C

Q31002124-89CC5A0F-E640-4C38-8FF5-0DFDF8A610FC

P304

Q31002124-01C7C0A0-D165-4E99-9D78-20266F760DE1

P31

Q31002124-A8E2BC2F-00B7-4494-ABB5-1D3001C1C39E

P356

Q31002124-E4CE1F4E-C40A-4599-985E-AF52E82AAD4E

P407

Q31002124-C471003D-D6BE-44CA-9ED4-B51D9957825C

P433

Q31002124-F641E37C-42E2-4FBF-8C99-47CCD9C1F7CB

P478

Q31002124-4E31B5A2-F656-4100-AC81-01F52E0AB180

P50

Q31002124-D5859BDA-C898-4A76-85D2-68C94E015B8E

P577

Q31002124-57845D13-4EEE-48E3-9061-A18666608EB2

P698

Q31002124-28C493B9-2F6C-4B1C-9B1D-B5F98EDFED38

P921

Q31002124-5CCBC74E-A5B9-416B-81C0-E85EC5F27ECB

Q31002124-ABAA092E-BC0A-4A42-B4E5-C6D7BB282486

P356

JCO.2005.04.031

P1433

Journal of Clinical Oncology

P1476

Treatment results in localized ...... icenter study (GIT NHL 02/96).

@en

P2093

Achim Heinecke

http://www.w3.org/2001/XMLSchema#string

Andreas Probst

http://www.w3.org/2001/XMLSchema#string

Carsten Hirt

http://www.w3.org/2001/XMLSchema#string

Eva-Maria Freitag

http://www.w3.org/2001/XMLSchema#string

Francisco del Valle

http://www.w3.org/2001/XMLSchema#string

Gabriele Reinartz

http://www.w3.org/2001/XMLSchema#string

Hermann Clasen

http://www.w3.org/2001/XMLSchema#string

Jens Brockmann

http://www.w3.org/2001/XMLSchema#string

Margit Hinkelbein

http://www.w3.org/2001/XMLSchema#string

Markus Tiemann

http://www.w3.org/2001/XMLSchema#string

P304

7050-7059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.04.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16129843

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial